For instance, the negative correlation in LIHC, MESO and THCA changed to a positive correlation, further suggesting that GPER1 is closely associated with the tumour immune microenvironment and ligand-receptor interactions between lymphocytes and malignant tumour cells, potentially influencing tumour progression and prognosis. This evidence concerns the gene GPER1 and neoplasm.